In Vitro Effects of Sulphasalazine, Azodisal Sodium, and Their Metabolites on Clostridium difficile and Some Other Faecal Bacteria
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 20 (5) , 607-612
- https://doi.org/10.3109/00365528509089704
Abstract
The effects of sulphasalazine (SASP), azodisal sodium (ADS), and their metabolites were tested in vitro on aerobic and anaerobic faecal bacterial strains. Sulphapyridine (SP) had a mild to moderate effect on Escherichia coli and Streptococcus faecalis. SASP also had a growth-inhibitory effect on Strep, faecalis. The other substances had no effect on the aerobic strains. SASP, SP, 5-aminosalicylic acid, and, to a certain extent, N-acetyl 5-aminosalicylic acid exerted a growth-inhibitory effect on the anaerobic strains. Of special interest was the inhibitory effect on Clostridium difficile strains. In recent years the possibility that overgrowth of CI. difficile could cause flare-ups of inflammatory bowel disease has been discussed. Some studies suggested that SASP treatment could predispose to CI. difficile superinfection, whereas others found SASP more probable to exert a prophylactic effect. Our findings support the theory that SASP treatment reduces rather than promotes the risk of CI. difficile superinfection.Keywords
This publication has 36 references indexed in Scilit:
- Absorption and Excretion of a Single 1-g Dose of Azodisal Sodium in Subjects with IleostomyScandinavian Journal of Gastroenterology, 1983
- Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.Gut, 1982
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973
- Absorption, metabolism, and excretion of salicylazosulfapyridine in manClinical Pharmacology & Therapeutics, 1972
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965
- Controlled trial of sulphasalazine in the treatment of ulcerative colitisGut, 1964